We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where ...

But it’s a slippery slope. When does reducing the risk of inherited breast cancer, diabetes, or Alzheimer’s disease edge into “designer baby” territory? As scientists grapple with the implications of ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Biotech and pharma companies are driving this growth, supported by collaborations and rising private funding for innovation and expanded CRISPR use. Rising incidence of chronic diseases: The rise in ...